Insights

More Articles Back to Article

EMA: Capillary leak syndrome an AZ vaccine side effect

The safety committee of the European Medicines Agency has identified capillary leak syndrome as another side effect that should be added to the labelling of AstraZeneca's COVID-19 vaccine Vaxzevria. The European drug regulator warned that those previously diagnosed with this condition should not be given the vaccine. Reuters (6/11)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!